- Home
- DRIO vs NTRB Comparison
DRIO vs NTRB Comparison
Compare DRIO & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DRIO | NTRB |
|---|---|---|
| Founded | 2011 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Specialties |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 82.2M | 71.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | DRIO | NTRB |
|---|---|---|
| Price | $11.89 | $5.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 1 |
| Target Price | ★ $50.00 | $13.00 |
| AVG Volume (30 Days) | ★ 31.4K | 23.4K |
| Earning Date | 11-13-2025 | 12-11-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $24,732,000.00 | $2,278,321.00 |
| Revenue This Year | N/A | $30.17 |
| Revenue Next Year | $20.02 | $3,394.36 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | 7.29 | ★ 12.69 |
| 52 Week Low | $5.94 | $3.72 |
| 52 Week High | $31.00 | $11.78 |
Technical Indicators
Market Signals| Indicator | DRIO | NTRB |
|---|---|---|
| Relative Strength Index (RSI) | 44.95 | 45.12 |
| Support Level | $11.77 | $4.60 |
| Resistance Level | $13.30 | $5.45 |
| Average True Range (ATR) | 0.90 | 0.37 |
| MACD | 0.03 | 0.10 |
| Stochastic Oscillator | 20.00 | 64.79 |
Price Performance
Historical ComparisonAbout DRIO DarioHealth Corp.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.